Status:
COMPLETED
Evaluation of Serum Taurine as a Prognostic Marker for Graft Function in Adult Egyptian Patients Undergoing Living Donor Liver Transplant
Lead Sponsor:
Ain Shams University
Conditions:
Taurine
Eligibility:
All Genders
18-70 years
Brief Summary
Although the hepatoprotective properties of taurine are well established, however the correlation of the perioperative serum level of this amino acid in the recipients of living donor liver transplant...
Detailed Description
* All selected adult patients undergoing LDLT will be admitted to the ICU post LDLT * Preoperative assessment and preparation will be done according to the standard protocol of the hospital. After ful...
Eligibility Criteria
Inclusion
- Recipient age ≥18 years.
- Donor age between 18 and 45 years
- ABO group compatibility with the recipient
- Normal psychological workup.
Exclusion
- Recipients patients with pre-existing renal failure requiring hemodialysis or continuous hemofiltration, glomerular filtration rate ≤ 30 ml /min by renal scan, ..
- Re-transplant
- HA1C \> 7%
- Pregnancy.
- Donors with fatty liver.
- Estimated remnant liver volume for donor is \< 30% of total liver volume.
- Donor body mass index \> 28 kg/m².
- Donor with abnormal biliary anatomy.
- Donor with steatosis \> 10%.
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04047043
Start Date
August 1 2019
End Date
May 30 2020
Last Update
August 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hanaa El Gendy
Cairo, Ain Shams University Specialized Hospital, Egypt